Titre du document / Document title

The nonapproved used of medications

Auteur(s) / Author(s)

LEE P. P. ⁽¹⁾ ; YANG J. C. ;

Affiliation(s) du ou des auteurs / Author(s) Affiliation(s)

⁽¹⁾ Johns Hopkins hosp., Wilmer ophthalmological inst., Baltimore MD, ETATS-UNIS

Résumé / Abstract

The need for new treatments for both established and recently described disorders has heightened awareness of the drug approval process. In particular, many ophthalmologists have questioned the ramifications of using approved drugs in nonapproved settings (such as apraclonidine) and the means of obtaining investigational drugs for patient use. The authors review the legal structures established to address these concerns and recommend approaches ophthalmologists can take to minimize their exposure to legal complications

Revue / Journal Title

Ophthalmology   ISSN 0161-6420   CODEN OPHTDG 

Source / Source

1991, vol. 98, n^o7, pp. 1071-1074 (28 ref.)

Langue / Language

Anglais

Editeur / Publisher

Elsevier, New York, NY, ETATS-UNIS  (1976) (Revue)

Mots-clés anglais / English Keywords

Drug ; Eye ; Novelty ; Public health organization ; United States ; Regulation ; Marketing ; Use ; North America ; America ;

Mots-clés français / French Keywords

Médicament ; Oeil ; Nouveauté ; Organisation santé ; Etats Unis ; Réglementation ; Commercialisation ; Utilisation ; Amérique du Nord ; Amérique ;

Mots-clés espagnols / Spanish Keywords

Medicamento ; Ojo ; Novedad ; Organización salud ; Estados Unidos ; Reglamentación ; Comercialización ; Utilización ; America del norte ; America ;

Localisation / Location

INIST-CNRS, Cote INIST : 18914, 35400001203539.0130